Diagnostic Value of Brain Tumor Neuroendoscopic Biopsy and Correlation with Open Tumor Resection

Abstract

Background The risks of stereotactic biopsy are increased not only in tumors located in the vicinity of vascular structures, but also in cystic, intraventricular, and periventricular lesions. The use of neuroendoscopy for cystic, intraventricular, or periventricular brain tumors is particularly advantageous because of the possibility of biopsy and immediate hemostasis under direct vision. Neuroendoscopy provides the possibility of controlling tumor-associated obstructive hydrocephalus by means of endoscopic third ventriculostomy or septostomy. The literature gives good evidence for the diagnostic benefits of neuroendoscopic biopsy. The correlation of the histology obtained by neuroendoscopic biopsy and subsequent surgical resection may allow the evaluation of the validity of diagnostic neuroendoscopic biopsy.

Materials and Methods Between 2003 and 2010, 23 patients with suspected cystic brain tumor (12 males; age range, 21–75 years; mean age, 49.7 years; and 11 females; age range, 22–76 years; mean age, 59.1 years) and 35 patients with intraventricular or periventricular brain tumors (19 males; age range, 6–80 years; mean age, 43.9 years; and 16 females; age range, 11–78 years; mean age, 46.2 years) underwent navigated neuroendoscopic biopsy.

Results Diagnostic samples were obtained in all cystic tumors and in 94.7% of intraventricular or periventricular tumors. Tumor resection after neuroendoscopic biopsy was performed in seven patients with cystic tumors. The results of the histological analysis of samples taken during endoscopic biopsy and surgical resection were identical in five of these patients (70.1%). Four patients with intraventricular or periventricular tumors underwent tumor resection after neuroendoscopic biopsy. The histological results of neuroendoscopic biopsy and tumor resection were identical in three patients (75%). Neuroendoscopic biopsy was performed in six patients with expansive pseudocyst after tumor resection and oncological therapy. The results of the neuroendoscopic biopsy matched the results of open surgery in four patients (66%). In the two remaining patients, there was a difference in tumor grading.

Conclusion The diagnostic accuracy of neuroendoscopic biopsy samples can be compared with the results of stereotactic biopsy. The histological results of endoscopically taken biopsy samples and the final histological results obtained during open surgery correlate in the majority of patients, and underlines the high diagnostic validity of neuroendoscopic biopsy.

Keywords

endoscopy - intracranial tumor - intraventricular tumor

• References

• 1 Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir (Wien) 2001; 143 (6) 539-545 , discussion 545–546
• 2 Tirakotai W, Schulte DM, Bauer BL, Bertalanffy H, Hellwig D. Neuroendoscopic surgery of intracranial cysts in adults. Childs Nerv Syst 2004; 20 (11–12) 842-851
• 3 Tirakotai W, Hellwig D, Bertalanffy H, Riegel T. The role of neuroendoscopy in the management of solid or solid-cystic intra- and periventricular tumours. Childs Nerv Syst 2007; 23 (6) 653-658
• 4 Ahmad F, Sandberg DI. Endoscopic management of intraventricular brain tumors in pediatric patients: a review of indications, techniques, and outcomes. J Child Neurol 2010; 25 (3) 359-367
• 5 Macarthur DC, Buxton N, Vloeberghs M, Punt J. The effectiveness of neuroendoscopic interventions in children with brain tumours. Childs Nerv Syst 2001; 17 (10) 589-594
• 6 Novák Z, Chrastina J, Říha I. Atlas of Neuroendoscopy. Praha: Maxdorf Jesenius; 2007
• 7 Prat R, Galeano I. Endoscopic biopsy of foramen of Monro and third ventricle lesions guided by frameless neuronavigation: usefulness and limitations. Clin Neurol Neurosurg 2009; 111 (7) 579-582
• 8 Fiorindi A, Longatti P. A restricted neuroendoscopic approach for pathological diagnosis of intraventricular and paraventricular tumours. Acta Neurochir (Wien) 2008; 150 (12) 1235-1239
• 9 Yurtseven T, Erşahin Y, Demirtaş E, Mutluer S. Neuroendoscopic biopsy for intraventricular tumors. Minim Invasive Neurosurg 2003; 46 (5) 293-299
• 10 Gaab MR, Schroeder HW. Neuroendoscopic approach to intraventricular lesions. J Neurosurg 1998; 88 (3) 496-505
• 11 Fukushima T. Endoscopic biopsy of intraventricular tumors with the use of a ventriculofiberscope. Neurosurgery 1978; 2 (2) 110-113
• 12 O'Brien DF, Hayhurst C, Pizer B, Mallucci CL. Outcomes in patients undergoing single-trajectory endoscopic third ventriculostomy and endoscopic biopsy for midline tumors presenting with obstructive hydrocephalus. J Neurosurg 2006; 105 (3, Suppl): 219-226
• 13 Depreitere B, Dasi N, Rutka J, Dirks P, Drake J. Endoscopic biopsy for intraventricular tumors in children. J Neurosurg 2007; 106 (5, Suppl): 340-346
• 14 Song JH, Kong DS, Seol HJ, Shin HJ. Transventricular biopsy of brain tumor without hydrocephalus using neuroendoscopy with navigation. J Korean Neurosurg Soc 2010; 47 (6) 415-419
• 15 Souweidane MM. Endoscopic surgery for intraventricular brain tumors in patients without hydrocephalus. Neurosurgery 2005; 57 (4, Suppl): 312-318 , discussion 312–318
• 16 Hellwig D, Bauer BL, List-Hellwig E. Stereotactic endoscopic interventions in cystic brain lesions. Acta Neurochir Suppl (Wien) 1995; 64: 59-63
• 17 Korinth MC, Weinzierl MR, Krings T, Gilsbach JM. Occurrence and therapy of space-occupying cystic lesions after brain tumor surgery. Zentralbl Neurochir 2001; 62 (3) 87-92
• 18 Cipri S, Gangemi A, Cafarelli F , et al. Neuroendoscopic management of hydrocephalus secondary to midline and pineal lesions. J Neurosurg Sci 2005; 49 (3) 97-106
• 19 Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M. Tumor recurrence and malignant progression of gangliogliomas. Cancer 2008; 113 (12) 3355-3363
• 20 Stüer C, Vilz B, Majores M, Becker A, Schramm J, Simon M. Frequent recurrence and progression in pilocytic astrocytoma in adults. Cancer 2007; 110 (12) 2799-2808